Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections
Open Access
- 13 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
Abstract
Endogenous mechanisms underlying bacterial infection resolution are essential for the development of novel therapies for the treatment of inflammation caused by infection without unwanted side effects. Herein, we found that erythropoietin (EPO) promoted the resolution and enhanced antibiotic actions in Escherichia coli (E. coli)- and Staphylococcus aureus (S. aureus)-initiated infections. Levels of peritoneal EPO and macrophage erythropoietin receptor (EPOR) were elevated in self-limited E. coli-initiated peritonitis. Myeloid-specific EPOR-deficient mice exhibited an impaired inflammatory resolution and exogenous EPO enhanced this resolution in self-limited infections. Mechanistically, EPO increased macrophage clearance of bacteria via peroxisome proliferator-activated receptor γ (PPARγ)-induced CD36. Moreover, EPO ameliorated inflammation and increased the actions of ciprofloxacin and vancomycin in resolution-delayed E. coli- and S. aureus-initiated infections. Collectively, macrophage EPO signaling is temporally induced during infections. EPO is anti-phlogistic, increases engulfment, promotes infection resolution, and lowers antibiotic requirements.This publication has 62 references indexed in Scilit:
- Non-traditional Antibacterial Therapeutic Options and ChallengesCell Host & Microbe, 2019
- Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulationJournal of Internal Medicine, 2018
- Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?Molecular Aspects of Medicine, 2017
- Host-directed therapies for bacterial and viral infectionsNature Reviews Drug Discovery, 2017
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanismsThe FASEB Journal, 2016
- Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsThe Lancet Infectious Diseases, 2016
- Specialized pro-resolving mediators: endogenous regulators of infection and inflammationNature Reviews Immunology, 2015
- Pro-resolving lipid mediators are leads for resolution physiologyNature, 2014
- Modulating immunity as a therapy for bacterial infectionsNature Reviews Microbiology, 2012
- Phagocyte partnership during the onset and resolution of inflammationNature Reviews Immunology, 2010